3,262 results on '"linagliptin"'
Search Results
102. BOEHRINGER INGELHEIM S A secures contract for Item Medicine No. 1 Linagliptin (tablets) (Code Article 68822)
103. Green and white MEKC for determination of different anti-diabetic binary mixtures and their triple-combo pill.
104. The combination of linagliptin and metformin rescues bone loss in type 2 diabetic osteoporosis.
105. QUANTIFICATION OF HAZARDOUS HIGH BOILING SOLVENTS IMPURITIES IN ANTI-DIABETIC DRUG LINAGLIPTIN BY NOVEL GC-ALS METHOD DEVELOPMENT AND VALIDATION.
106. Linagliptin ameliorated cardiac fibrosis and restored cardiomyocyte structure in diabetic mice associated with the suppression of necroptosis.
107. Indicadores de diabetes mellitus posterior a liraglutida, sitagliptina/metformina, linagliptina y sitagliptina.
108. Incident and recurrent hypoglycaemia with linagliptin and glimepiride over a median of 6 years in the CAROLINA cardiovascular outcome trial.
109. Synthesis of 1,2,3-Triazole Analogs of Linagliptin as Novel DPP-4 Inhibitors: DFT, Molecular Docking Approach.
110. Comparative Effectiveness of Glimepiride versus Linagliptin as add-on to Metformin in Type-2-Diabetes Mellitus.
111. Investigation of the effect of concurrently administered carvedilol, atorvastatin and bile salts on intestinal absorption of linagliptin.
112. Effects of DPP4 Inhibition on COVID-19
113. Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
114. Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry (DYDA2)
115. Development and validation of Empagliflozin and Linagliptin simultaneous estimation in rat plasma using freezing lipid precipitation and SCX-SPE assisted HPLC–MS/MS method and its application in pharmacokinetic studies
116. A cost-effectiveness analysis of linagliptin add-on to insulin treatment for patients with type 2 diabetes mellitus and chronic kidney disease in Iran
117. Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose (DIASA3)
118. Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19 (Covid19DPP4i)
119. SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of the Genito-urinary Tract and Risk of Infections. (UTI-flog)
120. QbD stressed development and validation of stability-indicating RP- HPLC method for the simultaneous estimation of linagliptin and metformin HCl in pharmaceutical dosage form
121. Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control.
122. HPLC-DAD technique for the quantification of a recently approved anti-diabetic triple combination along with two toxic official impurities: Toxicity confirmation aided by molecular docking application.
123. Development and validation of a new analytical method for determination of linagliptin in bulk by visible spectrophotometer.
124. The effect of linagliptin on microalbuminuria in patients with diabetic nephropathy: a randomized, double blinded clinical trial.
125. Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial.
126. Linagliptin and Mesenchymal Stem Cells: A Pilot Study
127. Supply Of Tab Lansoprazol 15mg, Tab Levetiracetam 500 Mg, Tab Levonorgestrel 025 Mg Ethinylestradiol 003mg, Tab Levonorgestrel 1 5mg, Tab Linagliptin 5mg, Tab Medroxy Progesterone 10 Mg, Tab Mefenemic Acid 250 Mg Dicyclomine Hydrochloride 10 Mg, Tab Melat
128. Effects of linagliptin on morphine dependence in larval zebrafish (Danio rerio)
129. Comparison of effects of Empagliflozin and Linagliptin on renal function and glycaemic control: a double-blind, randomized clinical trial
130. Contrast Nephropathy in Type 2 Diabetes (VCG4)
131. Effects of Linagliptin on Endothelial Function
132. The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors
133. Linagliptin Add-on to Insulin Background Therapy
134. Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus
135. This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood
136. Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Linagliptin/Metformin Extended Release Compared With Single Tablets
137. This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills
138. A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Healthy Volunteers
139. CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
140. GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS- invites tenders for Event No. 812-2024 Order 2840 Ref. 47624 Igss Code 10859 Linagliptin Coated Tablets 5Mg
141. GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS- invites tenders for Form A-01 Siaf No. 1944/2024 Igss Code 10859 Linagliptin Coated Tablets 5 Mg Amparo 01200-2016-00064
142. GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS- invites tenders for Order 1390/2024, Igss Code 10859, Linagliptin, Coated Tablets 5 Mg
143. Linagliptin treatment is associated with altered cobalamin (VitB12) homeostasis in mice and humans.
144. Dual inhibition of SGLT2 and DPP-4 promotes natriuresis and improves glomerular hemodynamic abnormalities in KK/Ta-Ins2Akita mice with progressive diabetic kidney disease.
145. Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis.
146. Micellar Thin Layer Chromatography and Computer-Aided Analysis of Empagliflozin, Linagliptin and Metformin HCl Ternary Mixture.
147. Architecting novel multilayer nanosponges for co-administration of two drugs managing high-risk type II diabetes mellitus patients suffering from cardiovascular diseases.
148. Linagliptin and Vitamin D3 Synergistically Rescue Testicular Steroidogenesis and Spermatogenesis in Cisplatin-Exposed Rats: The Crosstalk of Endoplasmic Reticulum Stress with NF-κB/iNOS Activation.
149. Management of Hyperglycemia in the Noncritical Care Setting: A Real-World Case-Based Approach With Alternative Insulin- and Noninsulin-Based Strategies.
150. A Review on HPLC Method Development and Validation for Gliptin Class: New Oral Antidiabetic Agents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.